HOME Press Releases Pyridine & Pyridine Derivatives Market worth 656.3 Million USD by 2021



Pyridine & Pyridine Derivatives Market worth 656.3 Million USD by 2021


The report "Pyridine & Pyridine Derivatives Market by Type (Pyridine, Beta Picoline, Alpha Picoline, Gamma Picoline), Application (Agrochemicals, Pharmaceuticals, Latexes, Food), Region (North America, Europe, Asia Pacific) - Global Forecast to 2021", The pyridine & pyridine derivatives market was USD 453.2 Million in 2015, and is projected to reach USD 656.3 Million by 2021, at a CAGR of 6.6%, from 2016 to 2021.

                                     Request Sample                                      Request Sample

Browse 144 market data tables and 38 figures spread through 168 pages and in-depth TOC on "Pyridine & Pyridine Derivatives Market by Type (Pyridine, Beta Picoline, Alpha Picoline, Gamma Picoline), Application (Agrochemicals, Pharmaceuticals, Latexes, Food), Region (North America, Europe, Asia Pacific) - Global Forecast to 2021"
http://www.marketsandmarkets.com/Market-Reports/pyridine-derivatives-market-36411434.html
Early buyers will receive 10% customization on reports.

The pyridine & pyridine derivatives market is driven by the increasing demand for pyridine & pyridine derivatives in applications such as agrochemicals and pharmaceuticals. Agrochemicals such as Symtet, Chlorpyrifos, and Diquat among others are driving the pyridine & pyridine derivatives market in the agrochemicals application. The demand for pyridine & pyridine derivatives in the pharmaceutical application is increasing as the demand for beta picoline is growing, which is majorly used in the manufacture of vitamin B3, which is further used in cosmetics and medicines.

The beta picoline type is estimated to lead the pyridine & pyridine derivatives market

Beta picoline type of pyridine & pyridine derivatives is majorly used in the pharmaceutical application, as it is used in the manufacture of vitamin B3 which is an important food additive used in nutritional food products, energy drinks, breakfast cereals, and yogurt, among others. Vitamin B3 (Niacin) is used in pharmaceutical applications such as for the treatment of skin diseases, to promote digestive functions, to lower the risk of high cholesterol, and for diabetes. It is estimated to be the leading pyridine & pyridine derivatives type in the market due to its growing use in diversified industries.

The pharmaceutical application is expected to be the fastest-growing application in pyridine & pyridine derivatives market

The pharmaceutical application is expected to be the fastest-growing application in the pyridine & pyridine derivatives market, followed by agrochemicals, latexes, food, and others. Pyridine is used to make beta picoline which is further used in the manufacture of vitamin B3.  Vitamin B3 (Niacin) is further used for the treatment of various diseases, and is also used in cosmetics and health related products. Pyridine is used in the manufacture of pharmaceuticals such as CNS stimulants, and local anesthetics. It is applied in the manufacture of sulfa drugs. Pyridine is the intermediate for anti-infectives (including cetylpyridinium), antihistamines (including chloropheniramine maleate). Also gamma picoline is used in the pharmaceutical industry for the manufacture of an anti-tuberculosis drug, Isoniazid.

The key companies profiled in the pyridine & pyridine derivatives market research report are Jubilant Life Sciences Ltd. (India), Vertellus Holdings LLC (U.S.), Lonza Group AG (Switzerland), Nanjing Redsun Co. Ltd. (China), Resonance Specialties Ltd. (India), Shandong Luba Chemical Co. Ltd. (China), Hubei Sanonda Co. Ltd. (China), Chang Chun Petrochemical Co. Ltd. (Taiwan), Koei Chemical Co. Ltd. (Japan), and C-Chem Co., Ltd. (Japan).

About MarketsandMarkets™

MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 5000 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

MarketsandMarkets’s flagship competitive intelligence and market research platform, "RT" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

Contact:
Mr. Rohan
MarketsandMarkets™
UNIT no 802, Tower no. 7, SEZ
Magarpatta city, Hadapsar
Pune, Maharashtra 411013, India
1-888-600-6441
Email: sales@marketsandmarkets.com

Connect Us

Follow us on LinkedIn  Follow us on Facebook   Follow us on Twitter 
Live Chat Support


US : 1-888-600-6441

Search reports